Skip to main content
Jason Lott, MD, Dermatology, New Haven, CT, Yale-New Haven Hospital

JasonPelhamLottMDMSHP

Dermatology New Haven, CT

Global Vice President Integrated Evidence Generation-Specialty Medicine, Integrated Care, & Cell-Gene Therapy Bayer Pharmaceuticals

Dr. Lott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lott's full profile

Already have an account?

Summary

  • I am a board certified dermatologist and health services researcher. I am interested in improving care, diagnosis, and outcomes associated with cutaneous disease.

Education & Training

  • Yale-New Haven Hospital
    Yale-New Haven HospitalPost-Doctoral Fellowship, Robert Wood Johnson Foundation Clinical Scholars Program, 2013 - 2015
  • Yale University
    Yale UniversityM.H.S., Health Services Research, 2014
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Dermatology, 2010 - 2013
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 2009 - 2010
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2009
  • University of Pennsylvania
    University of PennsylvaniaM.S., Health Policy, 2009
  • Brasenose College, Oxford University
    Brasenose College, Oxford UniversityBA/MA, Philosophy, Politics, and Economics, 2002 - 2004
  • University of Alabama at Birmingham
    University of Alabama at BirminghamB.S., Mathematics, 1998 - 2002
  • University of Alabama at Birmingham
    University of Alabama at BirminghamB.A., Philosophy, 2002

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2012 - 2024
  • PA State Medical License
    PA State Medical License 2009 - 2010
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Scholar National Cancer Institute Cancer Research Network (CRN), 2013
  • Clinical Scholar Robert Wood Johnson Foundation Clinical Scholars Program, Yale Univ. School of Medicine, 2012
  • Herbert and Faye Moskowitz Prize in Clinical Epidemiology Research University of Pennsylvania School of Medicine, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Commentary on: Asgari M, Interview by Thew M "Skin cancer prevention"  
    Lott JP, Cronin T, Dialogues in Dermatology, 5/1/2013
  • Commentary on: Ratner D, Interview by Brown S "Keratoacanthoma"  
    Lott JP, Girardi M, Dialogues in Dermatology, 2/1/2013
  • Patients with melanoma may benefit from 25(OH)D supplementation  
    Lott JP, DermClips, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Time to surgery for melanoma
    Lott JP, Solous PR, Aminwang J, Gross C, Robert Wood Johnson Foundation Clinical Scholars Program National Meeting, Atlanta, GA, 11/13/2013
  • Assessing primary care assets and access for adults with Medicaid through community-based participatory research
    Lott JP, Venkatesh A, Voorhees J, Weichers I, Robert Wood Johnson Foundation Clinical Scholars Program National Meeting, Atlanta, GA, 11/12/2013
  • Improving primary care access in New Haven through community-based participatory research
    Voorhees J, Weichers I, Lott JP, Venkatesh A, Curry L, Rosenthal M, Lucas G, North American Primary Care Research Group Annual Meeting, Ottawa, Canada, 11/1/2013
  • Join now to see all

Other

  • How to reduce deaths from cancer 
    Lott JP, New York Times
    1/5/2014
  • Costs versus benefits 
    Lott JP, New York Times
    11/25/2012
  • Does doctor know best? 
    Lott JP, New York Times
    6/11/2012
  • Join now to see all

Press Mentions

  • Reviewers' List December 2017
    Reviewers' List December 2017October 3rd, 2017
  • Melanoma Excision Frequently Delayed in Medicare Population
    Melanoma Excision Frequently Delayed in Medicare PopulationApril 8th, 2015
  • 1 in 5 Medicare Patients Faces Delay in Melanoma Surgery: Study
    1 in 5 Medicare Patients Faces Delay in Melanoma Surgery: StudyApril 8th, 2015

Professional Memberships

Hospital Affiliations